Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Capital Expenditures (2022 - 2025)

ASP Isotopes has reported Capital Expenditures over the past 4 years, most recently at $2.4 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 81.33% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.7 million, a 0.22% change, with the full-year FY2025 number at $9.7 million, changed 0.22% from a year prior.
  • Capital Expenditures reached $2.4 million in Q4 2025 per ASPI's latest filing, down from $3.1 million in the prior quarter.
  • The five-year high for Capital Expenditures was $4.5 million in Q3 2024, with the low at $146551.0 in Q2 2023.
  • The 4-year median for Capital Expenditures is $1.3 million (2024), against an average of $1.6 million.
  • Peak YoY movement for Capital Expenditures: crashed 82.42% in 2023, then surged 1689.19% in 2024.
  • Tracing ASPI's Capital Expenditures over 4 years: stood at $400000.0 in 2022, then skyrocketed by 185.3% to $1.1 million in 2023, then grew by 15.9% to $1.3 million in 2024, then skyrocketed by 81.33% to $2.4 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $2.4 million, $3.1 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.